Simple blood test could spare patients from unnecessary scans for dangerous condition
NCT ID NCT06609668
Summary
This study is testing whether a blood test measuring a protein called thrombomodulin can accurately tell which patients with polymyalgia rheumatica (PMR) also have a more serious condition called giant cell arteritis (GCA). Researchers will enroll 78 adults over 50 with PMR to see if this blood marker can identify those who need further imaging tests and those who don't. The goal is to develop a simpler way to screen for GCA, which requires stronger treatment to prevent serious complications like stroke or blindness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.